Home > Back to Publisher > Report Information

OTC Healthcare in South Africa to 2011

Datamonitor
August 11, 2008
188 Pages - SKU: DFMN1872772

Abstract Table of Contents Search inside this report Related Reports

Countries covered: South Africa

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in South Africa. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume, expenditure and consumption data by market, segment and subsegment
Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in South Africa increased between 2001-2006, growing at an average annual rate of 6.9%.

The leading company in the market in 2006 was Pharma Natura Limited. The second-largest player was Weleda Group with Pfizer Inc in third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 EXECUTIVE SUMMARY
: Summary Market Level - OTC Healthcare; Summary category level - Analgesics; Summary category level - Cough and Cold Preparations; Summary category level - Traditional Medicines; Summary category level - First Aid Kits; Summary category level - Indigestion Preparations; Summary category level - Vitamins and Minerals; Summary category level - Plasters & Bandages; Summary category level - Medicated Skin Products; Summary category level - Other OTC Healthcare Products; Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
: What is this report about?; How to use this report; Market Definition
Chapter 3 MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
: Pfizer Inc; Wyeth
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
: Value; Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
: Product launches over time; Recent product launches
Chapter 17 SOUTH AFRICA SOCIOECONOMIC PROFILE
: Country Overview; Key Facts; Political Overview; South Africa Economic Overview
Chapter 18 SOUTH AFRICA MACROECONOMIC PROFILE
: Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
Chapter 20 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: South Africa OTC Healthcare value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 2: South Africa OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: South Africa OTC Healthcare company share, by value, 2005-2006 (%); Figure 4: South Africa Analgesics value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 5: South Africa Analgesics category growth comparison, by value, 2001-2011; Figure 6: South Africa Analgesics company share, by value, 2005-2006 (%); Figure 7: South Africa Cough and Cold Preparations value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 8: South Africa Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: South Africa Cough and Cold Preparations company share, by value, 2005-2006 (%); Figure 10: South Africa Traditional Medicines value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 11: South Africa Traditional Medicines company share, by value, 2005-2006 (%); Figure 12: South Africa First Aid Kits value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 13: South Africa First Aid Kits company share, by value, 2005-2006 (%); Figure 14: South Africa Indigestion Preparations value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 15: South Africa Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 16: South Africa Indigestion Preparations company share, by value, 2005-2006 (%); Figure 17: South Africa Vitamins and Minerals value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 18: South Africa Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 19: South Africa Vitamins and Minerals company share, by value, 2005-2006 (%); Figure 20: South Africa Plasters & Bandages value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 21: South Africa Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 22: South Africa Plasters & Bandages company share, by value, 2005-2006 (%); Figure 23: South Africa Medicated Skin Products value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 24: South Africa Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 25: South Africa Medicated Skin Products company share, by value, 2005-2006 (%); Figure 26: South Africa Other OTC Healthcare Products value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 27: South Africa Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 28: South Africa Other OTC Healthcare Products company share, by value, 2005-2006 (%); Figure 29: South Africa Topical OTC Medicines value & value forecast, 2001-2011 (ZAR m, nominal prices); Figure 30: South Africa Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 31: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries; Figure 32: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries); Figure 33: Map of South Africa; Figure 34: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: South Africa OTC Healthcare value, 2001-2006 (ZAR m, nominal prices); Table 3: South Africa OTC Healthcare value forecast, 2006-2011 (ZAR m, nominal prices); Table 4: South Africa OTC Healthcare value, 2001-2006 (US$ m nominal prices); Table 5: South Africa OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices); Table 6: South Africa OTC Healthcare brand share, by value, 2005-2006 (%); Table 7: South Africa OTC Healthcare value, by brand 2005-2006 (ZAR m nominal prices); Table 8: South Africa OTC Healthcare company share by value, 2005-2006 (%); Table 9: South Africa OTC Healthcare value, by company, 2005-2006 (ZAR m nominal prices); Table 10: South Africa OTC Healthcare expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 11: South Africa OTC Healthcare forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 12: South Africa OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices); Table 13: South Africa OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 14: Pfizer Inc Key Facts; Table 15: Wyeth Key Facts; Table 16: South Africa Analgesics value, 2001-2006 (ZAR m, nominal prices); Table 17: South Africa Analgesics value forecast, 2006-2011 (ZAR m, nominal prices); Table 18: South Africa Analgesics value, 2001-2006 (US$ m nominal prices); Table 19: South Africa Analgesics value forecast, 2006-2011 (US$ m nominal prices); Table 20: South Africa Analgesics brand share, by value, 2005-2006 (%); Table 21: South Africa Analgesics value, by brand 2005-2006 (ZAR m nominal prices); Table 22: South Africa Analgesics company share by value, 2005-2006 (%); Table 23: South Africa Analgesics value, by company, 2005-2006 (ZAR m nominal prices); Table 24: South Africa Analgesics expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 25: South Africa Analgesics forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 26: South Africa Analgesics expenditure per capita, 2001-2006 (US$ nominal prices); Table 27: South Africa Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 28: South Africa Cough and Cold Preparations value, 2001-2006 (ZAR m, nominal prices); Table 29: South Africa Cough and Cold Preparations value forecast, 2006-2011 (ZAR m, nominal prices); Table 30: South Africa Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices); Table 31: South Africa Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 32: South Africa Cough and Cold Preparations brand share, by value, 2005-2006 (%); Table 33: South Africa Cough and Cold Preparations value, by brand 2005-2006 (ZAR m nominal prices); Table 34: South Africa Cough and Cold Preparations company share by value, 2005-2006 (%); Table 35: South Africa Cough and Cold Preparations value, by company, 2005-2006 (ZAR m nominal prices); Table 36: South Africa Cough and Cold Preparations expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 37: South Africa Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 38: South Africa Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 39: South Africa Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 40: South Africa Traditional Medicines value, 2001-2006 (ZAR m, nominal prices); Table 41: South Africa Traditional Medicines value forecast, 2006-2011 (ZAR m, nominal prices); Table 42: South Africa Traditional Medicines value, 2001-2006 (US$ m nominal prices); Table 43: South Africa Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 44: South Africa Traditional Medicines brand share, by value, 2005-2006 (%); Table 45: South Africa Traditional Medicines value, by brand 2005-2006 (ZAR m nominal prices); Table 46: South Africa Traditional Medicines company share by value, 2005-2006 (%); Table 47: South Africa Traditional Medicines value, by company, 2005-2006 (ZAR m nominal prices); Table 48: South Africa Traditional Medicines expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 49: South Africa Traditional Medicines forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 50: South Africa Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 51: South Africa Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 52: South Africa First Aid Kits value, 2001-2006 (ZAR m, nominal prices); Table 53: South Africa First Aid Kits value forecast, 2006-2011 (ZAR m, nominal prices); Table 54: South Africa First Aid Kits value, 2001-2006 (US$ m nominal prices); Table 55: South Africa First Aid Kits value forecast, 2006-2011 (US$ m nominal prices); Table 56: South Africa First Aid Kits brand share, by value, 2005-2006 (%); Table 57: South Africa First Aid Kits value, by brand 2005-2006 (ZAR m nominal prices); Table 58: South Africa First Aid Kits company share by value, 2005-2006 (%); Table 59: South Africa First Aid Kits value, by company, 2005-2006 (ZAR m nominal prices); Table 60: South Africa First Aid Kits expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 61: South Africa First Aid Kits forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 62: South Africa First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices); Table 63: South Africa First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 64: South Africa Indigestion Preparations value, 2001-2006 (ZAR m, nominal prices); Table 65: South Africa Indigestion Preparations value forecast, 2006-2011 (ZAR m, nominal prices); Table 66: South Africa Indigestion Preparations value, 2001-2006 (US$ m nominal prices); Table 67: South Africa Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 68: South Africa Indigestion Preparations brand share, by value, 2005-2006 (%); Table 69: South Africa Indigestion Preparations value, by brand 2005-2006 (ZAR m nominal prices); Table 70: South Africa Indigestion Preparations company share by value, 2005-2006 (%); Table 71: South Africa Indigestion Preparations value, by company, 2005-2006 (ZAR m nominal prices); Table 72: South Africa Indigestion Preparations expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 73: South Africa Indigestion Preparations forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 74: South Africa Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 75: South Africa Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 76: South Africa Vitamins and Minerals value, 2001-2006 (ZAR m, nominal prices); Table 77: South Africa Vitamins and Minerals value forecast, 2006-2011 (ZAR m, nominal prices); Table 78: South Africa Vitamins and Minerals value, 2001-2006 (US$ m nominal prices); Table 79: South Africa Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices); Table 80: South Africa Vitamins and Minerals brand share, by value, 2005-2006 (%); Table 81: South Africa Vitamins and Minerals value, by brand 2005-2006 (ZAR m nominal prices); Table 82: South Africa Vitamins and Minerals company share by value, 2005-2006 (%); Table 83: South Africa Vitamins and Minerals value, by company, 2005-2006 (ZAR m nominal prices); Table 84: South Africa Vitamins and Minerals expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 85: South Africa Vitamins and Minerals forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 86: South Africa Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices); Table 87: South Africa Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 88: South Africa Plasters & Bandages value, 2001-2006 (ZAR m, nominal prices); Table 89: South Africa Plasters & Bandages value forecast, 2006-2011 (ZAR m, nominal prices); Table 90: South Africa Plasters & Bandages value, 2001-2006 (US$ m nominal prices); Table 91: South Africa Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices); Table 92: South Africa Plasters & Bandages brand share, by value, 2005-2006 (%); Table 93: South Africa Plasters & Bandages value, by brand 2005-2006 (ZAR m nominal prices); Table 94: South Africa Plasters & Bandages company share by value, 2005-2006 (%); Table 95: South Africa Plasters & Bandages value, by company, 2005-2006 (ZAR m nominal prices); Table 96: South Africa Plasters & Bandages expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 97: South Africa Plasters & Bandages forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 98: South Africa Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices); Table 99: South Africa Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 100: South Africa Medicated Skin Products value, 2001-2006 (ZAR m, nominal prices); Table 101: South Africa Medicated Skin Products value forecast, 2006-2011 (ZAR m, nominal prices); Table 102: South Africa Medicated Skin Products value, 2001-2006 (US$ m nominal prices); Table 103: South Africa Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices); Table 104: South Africa Medicated Skin Products brand share, by value, 2005-2006 (%); Table 105: South Africa Medicated Skin Products value, by brand 2005-2006 (ZAR m nominal prices); Table 106: South Africa Medicated Skin Products company share by value, 2005-2006 (%); Table 107: South Africa Medicated Skin Products value, by company, 2005-2006 (ZAR m nominal prices); Table 108: South Africa Medicated Skin Products expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 109: South Africa Medicated Skin Products forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 110: South Africa Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 111: South Africa Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 112: South Africa Other OTC Healthcare Products value, 2001-2006 (ZAR m, nominal prices); Table 113: South Africa Other OTC Healthcare Products value forecast, 2006-2011 (ZAR m, nominal prices); Table 114: South Africa Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices); Table 115: South Africa Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices); Table 116: South Africa Other OTC Healthcare Products brand share, by value, 2005-2006 (%); Table 117: South Africa Other OTC Healthcare Products value, by brand 2005-2006 (ZAR m nominal prices); Table 118: South Africa Other OTC Healthcare Products company share by value, 2005-2006 (%); Table 119: South Africa Other OTC Healthcare Products value, by company, 2005-2006 (ZAR m nominal prices); Table 120: South Africa Other OTC Healthcare Products expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 121: South Africa Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 122: South Africa Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 123: South Africa Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 124: South Africa Topical OTC Medicines value, 2001-2006 (ZAR m, nominal prices); Table 125: South Africa Topical OTC Medicines value forecast, 2006-2011 (ZAR m, nominal prices); Table 126: South Africa Topical OTC Medicines value, 2001-2006 (US$ m nominal prices); Table 127: South Africa Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 128: South Africa Topical OTC Medicines brand share, by value, 2005-2006 (%); Table 129: South Africa Topical OTC Medicines value, by brand 2005-2006 (ZAR m nominal prices); Table 130: South Africa Topical OTC Medicines company share by value, 2005-2006 (%); Table 131: South Africa Topical OTC Medicines value, by company, 2005-2006 (ZAR m nominal prices); Table 132: South Africa Topical OTC Medicines expenditure per capita, 2001-2006 (ZAR, nominal prices); Table 133: South Africa Topical OTC Medicines forecast expenditure per capita, 2006-2011 (ZAR, nominal prices); Table 134: South Africa Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 135: South Africa Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 136: Global OTC Healthcare market value, 2006; Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries; Table 138: Leading players - Top 5 countries; Table 139: South Africa OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006; Table 140: South Africa OTC Healthcare new product launches (reports), by flavor and fragrances 2006; Table 141: South Africa OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006; Table 142: South Africa OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006; Table 143: South Africa OTC Healthcare new product launches (reports) - Recent 5 launches; Table 144: South Africa Key Facts; Table 145: South Africa population, by age group, 2000-2005 (millions); Table 146: South Africa population forecast, by age group, 2005-2010 (millions); Table 147: South Africa population, by gender, 2000-2005 (millions); Table 148: South Africa population forecast, by gender, 2005-2010 (millions); Table 149: South Africa real GDP, 2000-2005 (ZAR bn, 2005 prices); Table 150: South Africa real GDP forecast, 2005-2010 (ZAR bn, 2005 prices); Table 151: South Africa nominal GDP, 2000-2005 (ZAR bn, nominal prices); Table 152: South Africa real GDP, 2000-2005 (US$ bn, 2005 prices); Table 153: South Africa real GDP forecast, 2005-2010 (US$ bn, 2005 prices); Table 154: South Africa consumer price index, 2000-2005 (2000=100); Table 155: South Africa consumer price index, 2005-2010 (2000=100); Table 156: South Africa exchange rate, 2000-2005

More South Africa Over-the-Counter Drugs Reports

Medicated Skin Care in South Africa by Euromonitor International
Medicated skin care is characterised by intensive competition; such a trend restricted entry for new entrants during 2011. Skin care is very competitive and consumers ...

Herbal/Traditional Products in South Africa by Euromonitor International
Herbal/traditional products continued to grow in value and volume terms during 2011. The growth was stimulated by the increased need for healthier products by consumers. ...

Ear Care in South Africa by Euromonitor International
Ear care sales increased by 6% in value terms to reach a total of R30 million in 2011.This was a slight increase compared with the ...

Digestive Remedies in South Africa by Euromonitor International
Digestive remedies grew by 11% in current value terms during 2011. The changing lifestyles for most South Africans are influencing a general change in their ...

Cough, Cold and Allergy (Hay Fever) Remedies in South Africa by Euromonitor International
The changing weather and varying climate in South Africa continue to expose citizens to various forms of colds and flu. One city where this is ...

See all reports like this >>

More South Africa Reports

D&B Country RiskLine Report: South Africa by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

South Africa Patent Mapping Report by Intellectual Property Exchange
Patent Mapping Charts. As of date, there are 2129 patents from South African companies active in the United States Patent and Trademark Office. This set ...

D&B Country Report: South Africa by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

2007 South Africa Industry & Market Outlook report by Barnes Reports
The 2007 South Africa Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in South Africa and 500+ ...

The 2005 South Africa Economic and Product Market Databook by Icon Group International, Inc.
Market Potential Estimation Methodology Overview This study covers the outlook products in South Africa. For the year reported, estimates are given for the latent demand, ...

See all reports like this >>

OTC Healthcare in South Africa to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service